- Home
- HALO vs CHX Comparison
HALO vs CHX Comparison
Compare HALO & CHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- CHX
- Stock Information
- Founded
- HALO 1998
- CHX 1882
- Country
- HALO United States
- CHX United States
- Employees
- HALO N/A
- CHX N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- CHX Industrial Machinery/Components
- Sector
- HALO Health Care
- CHX Industrials
- Exchange
- HALO Nasdaq
- CHX Nasdaq
- Market Cap
- HALO 6.4B
- CHX 6.0B
- IPO Year
- HALO N/A
- CHX N/A
- Fundamental
- Price
- HALO $49.00
- CHX $31.24
- Analyst Decision
- HALO Buy
- CHX Buy
- Analyst Count
- HALO 9
- CHX 4
- Target Price
- HALO $61.11
- CHX $39.00
- AVG Volume (30 Days)
- HALO 2.3M
- CHX 1.7M
- Earning Date
- HALO 10-31-2024
- CHX 10-23-2024
- Dividend Yield
- HALO N/A
- CHX 1.22%
- EPS Growth
- HALO 61.71
- CHX 7.15
- EPS
- HALO 3.02
- CHX 1.62
- Revenue
- HALO $947,355,000.00
- CHX $3,665,501,000.00
- Revenue This Year
- HALO $23.36
- CHX N/A
- Revenue Next Year
- HALO $15.15
- CHX $3.90
- P/E Ratio
- HALO $16.21
- CHX $19.29
- Revenue Growth
- HALO 21.35
- CHX N/A
- 52 Week Low
- HALO $33.15
- CHX $25.46
- 52 Week High
- HALO $65.53
- CHX $39.95
- Technical
- Relative Strength Index (RSI)
- HALO 43.09
- CHX 56.97
- Support Level
- HALO $42.01
- CHX $30.28
- Resistance Level
- HALO $46.20
- CHX $32.08
- Average True Range (ATR)
- HALO 2.76
- CHX 0.77
- MACD
- HALO -1.08
- CHX 0.12
- Stochastic Oscillator
- HALO 34.74
- CHX 77.30
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About CHX ChampionX Corporation
ChampionX provides chemical solutions and equipment for onshore and offshore oil and gas production. Its engineering expertise spans the well lifecycle, but the firm maintains a particular focus on the production phase. Key offerings include artificial lift services and drilling technologies, specializing in polycrystalline diamond cutter inserts. ChampionX was formed after Apergy acquired its chemical technologies business from Ecolab in 2020.